8 results
Colorectal Cancer Screening and Polyp Surveillance Intervals
Colon Cancer Screening - Modality - Interval:
 • Colonoscopy -
Colorectal Cancer Screening ... Cancer Screening ... - Interval: • Colonoscopy ... Surveillance #Intervals #management ... #gastroenterology
Colorectal Cancer screening in ulcerative colitis per new UC guidelines
- Colonoscopy is the recommended method for
colitis per new UC guidelines ... #Cancer #CRC #Colon ... UlcerativeColitis #Guidelines ... #PrimaryCare #Gastroenterology ... #Management #Colonoscopy
Colon Cancer Screening Guidelines Modalities Intervals - For Average Risk Patients
#Diagnosis #PrimaryCare #ColonCancer #Colonoscopy #FOBT #FIT
Colon Cancer Screening ... Guidelines Modalities ... Patients #Diagnosis #PrimaryCare ... #ColonCancer #Colonoscopy ... #FOBT #FIT #Screening
Management of Large Colon Polyps
 - Inspect and Decide
 - Endoscopic Management
 - Post Resection

Summary by
Management of Large ... Colon Polyps - ... HassaanZiaMD #Large #Colon ... #treatment #endoscopy ... #colonoscopy #gastroenterology
Strategies to Improve Quality of Screening and Surveillance Colonoscopy - AGA Guidelines

1. Adequate bowel preparation.
2. Use
- AGA Guidelines ... look of the right colon ... Follow current guidelines ... #AGA #Guidelines ... #management #gastroenterology
ACA Colorectal Cancer Screening Guidelines

When to Screen?
When to Stop?
Family History

Performance Characteristics for Colorectal Cancer Screening Tests
Stool/blood-based
Guidelines When ... visualization: • Colonoscopy ... lesions or SSLs • Colon ... comparison #table #management ... #gastroenterology
Performance Characteristics for Colorectal Cancer Screening Tests
Stool/blood-based tests:
 • FIT: 79% sensitivity, 94% specificity for CRC
Colorectal Cancer Screening ... visualization: • Colonoscopy ... #Screening #Tests ... comparison #table #management ... #gastroenterology
Management of Immune Checkpoint Inhibitor (ICI) Induced Cardiotoxicity
Problem - Immune checkpoint inhibitors (ICIs) are associated with
✖ Current guideline ... abatacept for the treatment ... G2: Abnormal screening ... Cardiotoxicity #cardiology ... #treatment